Optibrium introduces StarDrop 5.4 to target novel, safe and efficacious drugs

Optibrium, a developer of software for drug discovery, today announced the release of version 5.4 of its StarDrop software platform.

 
Optibrium Ltd. 

Optibrium, a developer of software for drug discovery, todayannounced the release of version 5.4 of its StarDrop software platform. Itoffers enhanced features to guide the design of novel, safe and efficaciousdrugs by providing access to world-leading technologies for toxicity predictionand bioisosteric transformations. These new optional modules further extendStarDrop's capabilities to intuitively target high-quality compounds in drugdiscovery, reducing the time and cost to deliver drug candidates with animproved chance of success.
 


Optibrium Ltd.

www.optibrium.com

info@optibrium.com 

+44 1223 815900
 



Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Front Cover

Latest Issue  

• Volume 18 • Issue 12 • December 2022/January 2023

December 2022/January 2023

December 2022/January 2023 issue